Revance Therapeutics Inc.

NASDAQ: RVNC · Real-Time Price · USD
3.65
0.00 (0.00%)
Feb 05, 2025, 3:59 PM - Market open

Revance Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
137.33M108.97M110.62M333.56M171.16M73.26M282.9M63.5M
116.59M231.74M114.45M102.95M118.95M102.56Mn/a122.03M
6.87M6.05M5.05M3.44M730K730K580K580K
32.7M35.24M13.75M4.78M1.67M3.25M658K500K
27.68M11.34M3.35M1.83Mn/a27M48K6.03M
45.58M18.32M10.15M5.88Mn/a1.001.00978K
550K4.36M7.54M5.79M6.49M5.11Mn/an/a
338.87M374.73M246.12M450M296.6M207.92M285.21M192.69M
90.21M67.75M69M47.13M41.29M14.45M9.25M10.59M
9.81M104.18M202.3M218.31Mn/an/an/an/a
139.59M207.17M285.05M270.22M43.69M18.43M10.49M11.66M
478.45M581.9M531.16M720.22M340.29M226.35M295.7M204.36M
13.81M4.55M10.6M12.66M8.01M8.43M6.8M3.75M
10.74M6.87M9.36M7.85M7.91M8.59M11.52M11.76M
2.5M4.91M4.75M4.44Mn/an/a1.87M3.48M
22.69M26.43M22.48M17.49M11.09M5.93M1.01M7.12M
89.22M75.68M67.29M60.96M40.98M31.97M20.9M19.65M
426.6M379.37M280.63M180.53Mn/an/an/an/a
2.83M1.49M1.49Mn/an/a6.07M5.95M7.64M
540.83M493.62M395.4M284.97M73.82M48.76M5.95M7.64M
630.06M569.3M462.69M345.93M114.8M80.73M26.85M27.29M
478.43M418.47M324.51M212.11M29.34Mn/a1.87M5.35M
88K82K72K69K52K37K37K29K
-2.08B-1.75B-1.4B-1.13B-844.2M-684.77M-542.17M-421.54M
14K-374K-18Kn/a3K-8K-13.53M-45K
-151.6M12.6M68.47M374.29M225.49M145.62M268.85M177.07M
123.46M231.74M114.45M102.95M118.95M102.56M580K122.03M